Biosimilars are becoming quite the buzzword in cancer treatment, but cost, regulation, safety and efficacy are driving questions amongst payers and providers. In this webinar, NantHealth and a panel of respected medical experts examine:

  • The true definition of biosimilars and their potential in cancer care
  • The opportunities to drive down costs
  • Common misconceptions and concerns about safety and efficacy
  • Issues around payer reimbursement and provider incentives
  • The role of technology in navigating biosimilars

Download Webinar